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Abstract

Introduction

Scanning electron microscopy (SEM) ,
in the backscattered electron imaging
(BEI) mode , has been used to study the
topographical distribution of colloidal
gold labeled antigens expressed on the
luminal surface of the bladder urothelium
in biopsies from three categories of
patients: 1) normal controls; 2) patients
with a history of bladder cancer but no
pathological
diagnos i s
at
time
of
cystoscopy; and 3) patients with overt
transitional cell carcinoma (TCC) of
various
histopathological
stages
and
grades. Cold cup biopsies were processed
for immuno-SEM according to a previously
described
method .
Antigens
under
investigation were: 1) ABH blood group
antigens; and 2) those identified by the
following murine monoclonal antibodies
(mAbs): LEU-Ml, T16, 19A211, G4 and
E7. In most cases labeling patterns were
correlated with the surface features of
the superficial urothelial cells as
revealed
in
the
secondary electron
imaging (SEI) mode of the SEM . Results,
to date, indicate that the immuno-gold
labeling method is more sensitive than
immuno-peroxidase, and that phenotypic
heterogeneity of antigenic expression (or
deletion) is a frequent observation of
potential diagnostic or prognostic value.

A significant number of patients
with superficial bladder cancer progress
to muscle invasive disease . Currently,
there is no accurate method to identify
these patients (14). The aim of our study
is
to
characterize
the
antigenic
phenotype of superficial cells of the
bladder
urothelium,
normal
and
transformed at the resolution offered by
the
scanning
electron
microscope.
Immuno-labeling of the ABH antigens on
the surface of the bladder urothelium has
been
reported
previously,
using
bacteriophage T4 as marker recognizable
with the scanning electron microscope
( 12).
Immuno-labeling of
the ABH
antigens with colloidal gold has been
reported
by
Nakajima
et
al . in
a
transmission electron microscope study of
human
salivary
glands
(17). Other
antigens have been recently identified in
the transformed bladder urothelium (2 , 8,
9, 11); they have not, sofar, been
studied at the resolution offered by
electron microscope immuno-cytochemistry.
In our studies, we took advantage of
the striking elemental contrast generated
by gold particles when observed in the
backscattered electron imaging (BEI) mode
of the scanning electron microscope
(SEM)(4). The
advantages
of
using
backscattered electron imaging to study
antigenic expression on cell surfaces
became obvious to us during initial SEM
studies
on
human
peripheral
blood
leukocytes
and
have
been
recently
reviewed (5,7) . The method was then used
to study antigenic expression on the
luminal
surface
of
the
bladder
urothelium. Our initial targets were ABH
blood group antigens, known for being
partially
deleted
after
malignant
transformation, especially in cases of
invasive
bladder
neoplasia
( 3, 1 4, 18,19,21) . Ph en o t yp i c
heterogeneity in the deletion of the ABH
antigens was demonstrated in many cases
of non- invasive TCCs and was described
as a "Mosaic" labeling pattern ( 6) . The
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included the following main steps: a)
immediate transfer of the biopsied tissue
fragment to a fixative solution made of
buffered 0.1% glutaraldehyde and
3%
freshly
prepared
paraformaldehyde.
"Prefixation" time was routinely 10 mi.n,
at room temperature; b) after appropriate
rinses in PBS supplemented with 1%
ovalbumin and dissection of the mucosal
layer of the biopsy fragment, the mucosa
was incubated for 45 min with a 1/10
dilution of the relevant monoclonal
antibody (mAb); c) additional rinses wi.th
PBS/ovalbumin were followed by a second
incubation,
this
time with a
1/10
dilution of
a
class
specific
goat
anti-murine Ig adsorbed on the surface of
40 or 30 nm colloidal gold particl.es
(GAM-G40, or G30, Janssen Pharmaceutica,
Beerse, Belgium); d) "postfixation" for 2
hours with 2.5% buffered glutaraldehyde;
e) graded ethanol dehydration and dryi.ng
at the critical point of CO 21 preceded
conductive
coating
with
evaporated
carbon; f) storage of the samples in
desiccators until examination with the
SEM; g) for scanning electron microscopy
a JEOL JSM #840 instrument was used
throughout. The microscope was equipped
with
a
lanthanun1
hexaboride
(LaB 6 )
cathode (Denka, Mitsui & Cy, Tokyo,
Japan), and with a "GW #115" Summing Unit
(GW Electronics, Inc., Norcross, GA) to
permit the mixing of secondary (SE) and
backscattered electron (BE) signals in
adequate proportions.
In all control experiments step b)
was
omitted
or
substituted
by
an
irrelevant mAb.
Biopsies of bladder mucosa were
collected from:
1)
"normal" control
patients, after written consent, and
during surgery for the correction of
urinary stress incontinence or of other
non-neoplastic
or
non-inflammatory
urinary conditions;
2)
a
group of
patients with a well documented history
of
bladder
cancer
but
with
no
pathological diagnosis (NPD/TH) at the
time of cystoscopy and cold cup biopsy of
bladder mucosa; 3) cases of bladder
transitional cell carcinoma (Ta to T3,
grades 1 to 3); in these cases, the cold
cup biopsies were taken from the tumor
itself, not from adjacent or surrounding
mucosa.
Biopsies were frequently divided to
test several antibodies on the same
sample. The total number of labeling
experiments is reported in Tables 1 and

Abbreviations Used
SEM:

scanning electron microscopy

SE:

secondary electrons

BE:

backscattered electrons

TCC:

transitional cell carcinoma

mAb:

monoclonal antibody

NPD/TH:

no 2athological giagnosis but
_tumour history

PBS:

phosphate buffer saline

ABH:

blood group antigens

word "Mosaic" was chosen to emphasize
different levels of expression of the
antigen on the
luminal
surface of
adjacent cells, sharply delineated along
well recognized, polygonal cell borders.
We now report results dealing not
only with antigens deleted during some
steps of the transformation process, but
also with antigens characteristically
expressed by the transformed bladder
urothelium, such as those described over
the past few years by Chopin et al. (2),
Fradet et al. ( 8, 9) and Hos hi et al.
(11). The
significance
of
our
investigations has been enhanced by
access
to
two
distinct
groups
of
patients: 1) a "normal control" group
undergoing surgery for the correction of
urinary stress incontinence or other
non-neoplastic
and
non-inflammatory
bladder conditions; and 2) a group of
patients which is hereby referred to as
"NPD/TH", i.e. no 2athological giagnosis
at time of biopsy of the bladder mucosa
but with well documented bladder _tumor
history.
The rationale of our studies is
linked to the following hypotheses:
1) high resolution immuno-gold labeling
of bladder biopsies with the SEM reveals
phenotypic
changes
in
antigenic
expression which
are
of
prognostic
significance and would not have been
recognized with immune-peroxidase or with
flow cytometry methods;
and 2) the
antigenic phenotype of the superficial
cells of the urothelium reflects, as a
slightly
delayed
testimony,
primary
transformation events occuring in the
basal cell layer of the urothelium.

2.

Material and Methods

Surface
expressed
antigens
investigated in this study were: 1) ABH
blood
group
antigens
recognized
by
appropriate
monoclonal
antibodies
(Dakopatts a/s, Denmark); 2) antigens
identified
by
LEU-Ml
(10,
BectonDickinson, Mountain View, CA), T16 and
19A211 (8,9), and G4 and E7 (2) murine

Cold cup or excision biopsies were
collected at cystoscopy using "Plasmalyte" (Travenol Canada Inc., Mississauga,
Ontario) as an irrigation fluid and
processed for immuno-SEM according to a
previously described method (6) which
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present study, no significant difference
in labeling pattern was recognized among
patients belonging to blood group A, B,
AB, or O.
Unexpectedly, homogeneous
expression of the antigen was observed in
4 cases of high grade TCC ( *, in Table
1). Reviewing the
histopathological
diagnosis in these cases, one case showed
a
submucosal
tumor
covered
by
an
apparently normal mucosa. In another case
multiple biopsies had been taken for
histopathology making it difficult to
ascertain which one was equivalent to the
sample processed for SEM.
One example of "mosaic" labeling
pattern is illustrated in Fig.1 a and b
which originates from a patient from the
NPD/TH group.
Fig. la illustrates the
surface morphology of representative
cells viewed in the SE imaging mode.
Fig. lb shows the same field in the BE
imaging
mode,
demonstrating
the
heterogeneous deletion of the antigen,
i.e. the
mosaic
pattern,
clearly
delineated along cell borders.
The complete "deletion" could in
some cases be interpreted as originating
from "non-secreter" patients.
Mosaic
patterns of ABH labeling were observed in
52% of the NPD/TH cases and in 55% of the
low grade TCC cases. The high incidence
of "deletion" ( 20/28) in cases of high
grade TCC is probably somewhat in excess
due in part to the frequent desquamation
of the superficial cells and in part to
the
defective
maturation
of
the
transformed cells.
Tumor Associated Antigens
Ninety-seven samples were analyzed
in this part of the study. There were 19
normal controls, 41 from the NPD/TH
group, 11 from patients with low grade
TCC, and 26 from patients with high grade
TCC. The results were classified as
"positive"
or
"negative",
without
specific reference to the homogeneous or
heterogeneous labeling pattern. Results
are expressed as the number of positive
identifications
of
a
given
antigen
divided by the number of examined samples
and are tabulated in Table 2.
Examples of labeling patterns are
illustrated
as
follows.
Fig. 2
illustrates positive labeling for the
antigen identified by the LEU-Ml rnAb in a
normal control sample. Fig. 3 documents
phenotypic heterogeneity (i.e. "mosaic")
in the expression of the LEU-Ml antigen
in a NPD/TH case.
Fig. 4 a and b
illustrate
the
particular
labeling
pattern for the Tl6 antigen observed in a
TCC grade 2, where the labeling of
intermediate, villous cells is recognized
through a window of desquamation of the
superficial "umbrella" cells.
Fig. 5 a
and b show, in a NPD/TH case labeled with
the G4 rnAb, the surface morphology of a
superficial cell characterized by plaques
and microridges (Fig Sa) while Fig. Sb,

monoclonal antibodies (rnAbs).
Histopathological
controls
were
studied
in
all
cases. Grading
was
according
to
the
World
Health
Organization's classification (16). In
addition, whenever a discrepancy was
noted between the histopathological grade
of a given tumor and the appearance of
the mucosa under the SEM, the SEM sample
was, after thorough SEM examination,
embedded in paraffin and the histopathological grade reconsidered under the
light microscope.
Results
The results dealing with deletion of
ABH antigens and those illustrating
expression of tumor associated antigens
will be presented separately.
ABH Antigens
A total
of
104
biopsies were
included in this part of the study. They
originated from 11 cases of normal
controls, 36 cases with well documented
history
of
bladder
cancer
but
no
pathological diagnosis at the time of
biopsy (NPD/TH cases), 29 cases of low
grade and 28 cases of high grade TCCs.
The
labeling
patterns
were
classified into three arbitrarily defined
groups: homogeneous
labeling of most
adjacent cells, phenotypic heterogeneity
i.e. "mosaic"
labeling
pattern,
and
predominantly
or
completely
deleted
expression of the antigen.
The results
are summarized in Table 1, the labeling
patterns
being
referred
to
as
"homogeneous", "mosaic" or "deletion".
Table 1. Expression of the ABH Antigens
on
Superficial
Cells
of
Bladder
Urothelium
Clinical
data

ABH Expression
Homog Mosaic Delet

Contr. (n=ll)

10

1

0

NPD/TH (n=36)

15

19

2

Low gr. TCC (n=29)

7

16

6

High gr. TCC (n=28)

4(*)

4

20

-------------------------------------The secretor status of the patients
included
in
this
study
was
not
systematically tested. A small percentage
(probably less than 10%) of the deleted
expression may, therefore, be accounted
for
by
a
hypothetical
non-secreter
status. Low grade TCC included grade 1
tumors while high grade TCC referred to
grade 2 and 3. As already noted in our
initial report (6) and confirmed in the
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Fig. la.
Bladder biopsy from a patient from the NPD/TH group,
viewed in the secondary electron (SE) imaging mode.
Large
polygonal superficial cells display the plaques and microridges
characteristic of the normal urothelial surface.
Imrnunogold
labeling for the blood group antigen cannot be recognized in the SE
imaging mode.
Fig. lb. The same field as in Fig . la, viewed in the backscattered
electron (BE) imaging mode.
The colloidal gold markers is now
clearly recognized on the surface of some of the cells, while
sparsely represented or totally absent on others, therefore
creating a typical mosaic labeling pattern.
470
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Fig . 2 . Bladder biopsy from the normal control group, immune-gold
labeled with the LEU-Ml mAb.
Heavy labeling of the superficial
cells is observed here in a mixed SE/BE image.
Fig. 3.
In a case from the NPD/TH group, also labeled with the
LEU-Ml mAb, a characteristic mosaic labeling pattern is observed in
the BE imaging mode (reverse polarity).
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Fig. 4a. Bladder biopsy from a patient with TCC grade II, labeled
with the T16 rnAb.
Through windows of desquarnation of the
superficial cells, urothelial cells of the intermediate layer are
observed, in the SE imaging mode; they display an abundance of
surface microvilli.
Fig. 4b.
The same field as in Fig. 4a, viewed in the BE imaging
mode, demonstrating significant labeling for the antigen recognized
by the T16 rnAb on the villous cells of the intermediate layer.

472

SEM OF GOLD LABELED BLADDER ANTIGENS

..

,.

~· -·
. .

.

Sb·

..

.,.

•

~

...

..

·•!

•

-. •

..,,.

,· .

JI'

I

•

•

·. •,

•

Fig. Sa.
Bladder biopsy from a patient from the NPD/TH group,
labeled with the G4 rnAb.
The plaques and microridges are well
recognized in the SE imaging mode.
Fig. Sb.
The same field as in Fig. Sa, viewed in the BE imaging
mode (reverse polarity), clearly demonstrating that most of the 30
nm gold marker particles are located on the microridges, not on the
intervening plaques of this superficial urothelial cell.
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mixed anatomical origin were studied .
Moreover,
in
many
light
microscopy
studies of bladder biopsies combined with
various approaches to immunolabeling, the
"mosaic"
also
remained
undetected,
because cross-sections of the mucosal
surface were studied. The face-view o f
relatively large areas of the bladder
mucosa offered by the SEM, combined with
the high resolution of the instrument are
unquestionably needed to observe this
particular labeling pat tern .
Antigenic
expression
in bladder
neoplasia
has
to
be
compared with
appropriate normal control samples of
bladder mucosa . Our controls consisted of
mucosal biopsies collected during surgery
for the correction of non-neoplastic and
non-inflammatory bladder conditions such
as
urinary stress
incontinence, from
female patients belonging to the 40-50
year age group . These controls minimize
the effects of age and the interference
by inflammatory or neoplastic processes.
We have identified the LEU-Ml antigen i n
most of our control samples, at variance
with the results reported by Hoshi et
al. ( 11) . One
explanation
of
this
discrepancy may reside in our selection
of better controls. Another explanation
may involve the high sensitivity of t h e
immune-gold labeling method which detec t s
low levels of antigenic expression in the
normal bladder mucosa, undetectable by
peroxidase
immune-cytochemistry . It
should be emphasized also that the
antigen recognized by the LEU-Ml mAb was
initially demonstrated on the surface of
normal,
non-transformed
human
myelomonocytic cells (10), and cannot,
therefore,
be
regarded
as
tumorassociated.
All the monoclonal antibodies tested
so far gave some positive labeling in
control samples. This cannot be explained
by
non-specific
background
labeling
because control experiments, in which the
primary monoclonal antibody was either
omitted or substituted by an irrelevant
mAb,
gave totally negative labeling
results. Rather, these findings support a
statement recently made, "the search for
specific markers of low grade papillary
superficial bladder tumors had long been
unsuccessful, probably due to the close
resemblance of these cells to their
normal
counterpart"
( 9) .
Cancerprogress ion
antigens
( 9)
should
be
studied
by
immune-gold
labeling
in
further
attempts
to
validate
this
interpretation.
The phenotypic heterogeneity which
we initially observed in the deletion of
the blood group antigens ( 6) , is also
occasionally observed in the expression
of other antigens such as that identified
by the LEU-Ml mAb
(Fig.
3).
The
significance of these observations is not
presently clear.
They may, however,

Table 2. Expression of Tumor
Associated Antigens on the Superficial
Cells of the Bladder Urothelium
Clinical
data

Antigen identified by
monoclonal antibodies:
G4

Norm. Contr 2/3
(n=l9)
NPD/TH
(n=41)

E7
1/2

11/13 7/11

T16 19A211 LEU-Ml
6/6(*) 1/2

5/6

8/8

5/6

2/3

3/3

2/3

2/2

1/1

2/2

High gr.TCC 4/5
(n=26)

5/6

3/4

2/2

9/9

Low gr.Tee
(n=ll)

Note that positive labeling with the T16
mAb in normal control(*) was restricted
to urothelial cells of the intermediate
layer,
occasionally observed through
little "windows" of desquamation of the
superficial cells.
taken in the BE imaging mode of the SEM,
clearly indicates that the majority of
the gold labeled sites are localized on
the crests of the microridges, but not on
the plaques of this apparently normal
urothelial luminal surface.
Our analysis of antigenic expression
has been restricted to mucosal biopsies
i n normal controls, in NPD/TH cases, and
to tumor biopsies in the cases of low and
high grade TCCs. It did not involve
mucosal biopsies adjacent to tumors and
therefore does
not
illustrate tumor
associated " field changes " (14) .
Discussion
Our results indicate that, as far as
the deletion of the ABH blood group
antigens
is
concerned,
observations
cannot be classified in "positive " or
"negative " as was frequently done in the
past, although zones of heterogeneous
expression of the ABH antigens were
detected by light microscopy immunofluorescence by Vacant et al. (20). When
viewed with the SEM after immune-gold
labeling, adjacent superficial cells with
very similar ultrastructure (6) express
strikingly different amounts of antigen
(the
"mosaic"
pattern) . This
mosaic
pattern of labeling was rarely observed
in normal controls but was present in
more than 50% of NPD/TH cases and low
grade TCCs. In previous studies of cells
from the urinary sediment, the "mosaic"
type of deletion was never demonstrated
(18), because single cell suspensions of
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reflect early changes taking place in the
basal cell layer of the urothelium.
If
this would prove to be the case, the
phenotype of the superficial urothelium
might be regarded as offering a slightly
delayed
testimony
of
primary
transformation events taking place in the
basal cells.
Finally, the immuno-gold labeling of
antigens expressed on the luminal surface
of
the
bladder
urothelium
permits
unequivocal
correlations
between the
topographical distribution of certain
antigen and ultrastructural features of
cell surfaces. This is best illustrated
in the case of the G4 mAb ( 2) which
recognizes
an
antigen
only on
the
microridges of the superficial cells, not
on the
intervening
"plaques"
of an
asymmetric unit membrane (1,13). Further
experiments will be needed, however, to
verify
that
the
antigen
is
not
efficiently masked on the plaques, while
being
readily
accessible
on
the
microridges. Whatever
final
interpretation
is
reached,
the
observation could not have been made
without the high resolution of the
immuno-gold/SEM labeling method.
In conclusion, immuno-gold labeling
combined
with
scanning
electron
microscopy in the backscattered electron
imaging mode has provided a new approach
to study the antigenic phenotype of the
luminal surface of the human bladder
urothelium, normal and transformed. The
observations presented in this study
could
not
have
been
made
at
the
resolution of light microscope immunocytochemistry or by flow cytometry. The
immuno-gold/SEM methodology is relatively
simple,
highly
reproducible,
and
comparatively inexpensive. A one to two
year follow-up on all the NPD/TH patients
entered in this study is presently in
progress and should establish whether or
not
the
observation
of
a
"mosaic"
deletion of ABH antigens is relevant to
the
clinical
prognosis
of
invasive
disease of the bladder.
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surface antigens?
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bladder
biopsies
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attempts to answer these interesting
questions.
R.
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Albrecht:
Are
there
any
distinguishing morphological, cytological
or cytochemical features specific to the
negative cells?
Authors:
Yes, there is a tendency for
the negative cells to exhibit only sparse
surface features.
G. M. Hodges:
What are the advantages
provided by the GW115 Summing Unit for
the mixing of secondary and backscattered
electron signals over and above that
available on the JEOL JSM840 instrument:
Please
detail
the
address
of
GW
Electronics.
Authors:
The advantage resides in the
possibility
to
control
the
exact
proportion of the SE/BE signals mixing,
instead of simply adding them up.
The
address
of
the
company
is:
GW
Electronics
Inc.,
6981
Peachtree
Industrial Boulevard, Norcross, GA 30092.
G. M. Hodges: What evidence do you have
that the cells labeled in Fig 4a and b
are "intermediate" ce 11 s?
Furthermore,
it is surely inappropriate to call these
cells "villous cells".
The term of
"villous" is generally applied to fingerlike
tissue
processed
such
as
intestinal/placental/ or chorionic villi.
The individual cells that are part of
such villi may be themselves patterned by
microvilli projecting from the free
surface of these cells (as, for example,
illustrated in Fig 4a).
Authors:
Low magnification observation
of that sample clearly demonstrated that
the cells represented in Figs 4a and b
were seen through a well delineated
"window" of desquamation of one or a few
superficial cells.
We use the term
"villous" in the same sense as it is
routinely used in the SEM literature on
"villous" lymphocytes, al though this does
not, as you point out, correspond to the
traditional, anatomical definition of the
word.

Discussion with Reviewers
R.M. Albrecht:
Were biopsies that were
mosaics for the blood group antigens also
mosaics for the Leu-Ml antigen or other
antigens?
Authors: Samples labeled for blood group
antigens were usually not labeled for
tumor associated antigens. We could not,
therefore, establish such a correlation.

R.M.
Albrecht:
Have
the
authors
performed any double labeling studies to
determine if the negative cells, in the
mosaic pattern, are negative for all
surface markers or selectively negative
for one or more of the antigens? In the
presence of the mosaic pattern can one
population of cells be negative for one
antigen while a different population of
cells is negative for a second antigen

S. M. Cohen:
Was there any evidence of
hyperplasia in the biopsies from controls
or
NPD/TH
by
light
microscopic
histopathology?
Authors: None was reported, in spite of
the fact that all the histopathological
slides were reviewed prior to insertion
in this study.
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S. M. Cohen: Was there any relationship
of
antibody expression
to
specific
surface
features
such
as
uniform
microvilli,
pleomorphic
microvilli,
spaces between microvilli, microridges,
cell junctions, etc.?
Authors: Yes, the most interesting being
probably that observed with the G4
antibody which seems to recognize an
antigen
restricted
to
microridges,
although
we
did
not
perform
any
experiment aimed at possibly unmasking
the antigen in other sites.
For other
antibodies, there is a general tendency
to label microvilli more intensely than
the space between microvilli. So far, we
never observed any specific distribution
of the antigens under investigation along
cell junctions of the superficial cells.
J.B. Reitan:
On fig. 1 a/b a mosaic
labeling pattern is demonstrated.
The
cell without ABH-antigen marking up to
the right looks normal in SE-mode to me,
whereas those at the bottom are somewhat
blurred.
Is it an artifact or may be
they are not really normal?
Authors: You are right. We do not feel,
however, that these cells are out of
focus because, in that case the gold
would no show as well as it does on the
bottom center cell.
We are left,
therefore, with the possibility that the
morphology of these few cells has been
poorly preserved.
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